Related Experiment Video
Updated: Feb 3, 2026

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
C1q/TNF-related protein 9: A novel therapeutic target in ischemic stroke?
Cui Yang1,2, Fan Fan1,2, Darrell Sawmiller3
1Department of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Insights
C1q/TNF-related protein 9 (CTRP9) may protect brain tissue and reduce severity in ischemic stroke. This adipokine shows promise as a biomarker and therapeutic target for stroke prevention and treatment.
Area of Science:
- Cardiovascular Research
- Neurology
- Endocrinology
Background:
- Ischemic stroke is a major public health concern requiring advanced research.
- C1q/TNF-related protein 9 (CTRP9), an adipokine, is crucial in coronary atherosclerosis disease (CAD) pathogenesis.
- CAD and ischemic stroke share common vascular disease mechanisms.
Purpose of the Study:
- To investigate the potential neuroprotective role of CTRP9 in ischemic stroke.
- To explore CTRP9 as a biomarker and therapeutic target for ischemic stroke.
Main Methods:
- Review of existing research on CTRP9 in cardiovascular and cerebrovascular diseases.
- Analysis of shared pathogenetic mechanisms between CAD and ischemic stroke.
Main Results:
- CTRP9 demonstrates protective functions in CAD, including metabolic regulation, vasodilation, endothelial protection, and plaque stabilization.
- Shared vascular pathogenesis suggests potential for CTRP9 to impact ischemic stroke.
Conclusions:
- CTRP9 may protect brain tissue and mitigate lesion severity in ischemic stroke.
- CTRP9 is proposed as a potential biomarker and therapeutic target for ischemic stroke.
Abstract:
Ischemic stroke has become a serious public health problem, which is in need of advanced research on the prevention and treatment. As a newly discovered adipokine, C1q/TNF-related protein 9 (CTRP9) plays a vital role in the pathogenesis of coronary atherosclerosis disease (CAD), including regulating energy metabolism, modulating vasomotion, protecting endothelial cells, inhibiting platelet activation, inhibiting pathological vascular remodeling, stabilizing atherosclerotic plaques, and protecting heart. The present review raised a critical question of whether CTRP9 could also have the capacity of protecting the brain tissue and decreasing the severity of brain lesions in the ischemic stroke since CAD and ischemic stroke are both the major subtypes of atherosclerotic vascular diseases which share a large of common pathogenesis in the vascular lesion particularly. Therefore, we proposed that CTRP9 could be a feasible biomarker and potential therapeutic target in ischemic stroke on the basis of the reviewed research reports.
Related Concept Videos
Therapeutic Index
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Microorganisms in Medicine and Therapeutics

